MEETING PROGRAMME


SCOPE AND PURPOSE OF THE MEETING

Sunday, 24 June 2001

16.00-18.30 REGISTRATION

19.00-21.00 RECEPTION

Monday, 25 June 2001

08.00-08.30 REGISTRATION

Session 1 Opening session

Chair: Harold Margolis and André Meheus

09.00 – 09.25 Welcome by:

Roberto Bertollini, WHO
Vladimir Zhelobov, St.Petersburg Health Care Committee
Alexander Malyavin, Unicef
Mark Kane, Children’s Vaccine Program

09.25-09.40 Review of the objectives of the meeting and technical introduction. Johannes Hallauer

09.40 – 10.00 Overview of GAVI and the Global Fund for Children’s Vaccines. Mark Kane Download Powerpoint document (approx. 729kb)

Session 2 Hepatitis B epidemiology and vaccination programmes

Chair: Harold Margolis and André Meheus

10.00 – 10.20 Global epidemiology of hepatitis B and review of prevention strategies in the world. Eric Mast Download Powerpoint document (approx.724kb)

10.20 – 10.40 Overview of the hepatitis B, C and D epidemiology in CEE and NIS countries. Michael Favorov Download Powerpoint document (approx. 130kb)

10.40 – 11.00 Review of the hepatitis B vaccination programmes and the progress made since Siofok, 1996 in CEE and NIS countries. Nedret Emiroglu. Download Powerpoint document (approx. 528kb)

11.00 – 11.20 Coffee Break

Session 3 Hepatitis B vaccines: technical basis and injection safety

Chair: Peter Grob and Daniel Shouval

11.20 – 11.40 Hepatitis B vaccines: safety and side-effect profile. Philippe Duclos Download Powerpoint document (approx. 171kb)

11.40 – 12.00 Hepatitis B vaccines: quality, immunogenicity. Susan Goldstein Download Powerpoint document (approx. 144kb)

12.00 – 12.20 Safe immunisation practice and prevention of Hepatitis B and C infections. Susan Mackay Download Powerpoint document (approx. 1710kb)

12.20 – 12.50 Discussion on sessions 1,2,3

12.50 – 14.00 Lunch

Session 4 hepatitis B Prevention strategies and Programme Evaluation

Chair: Eric Mast and Alexander Malyavin

14.00 – 14.25 Hepatitis B prevention strategies in the broader context of hepatitis B and C prevention. Harold. Margolis Download Powerpoint document (approx. 586kb)

14.25 – 14.50 Outcome evaluation and impact assessment. Susan Goldstein Download Powerpoint document (approx. 447kb)

14.50 – 15.10 Discussion

Country experiences: (15 minutes presentation by a country representative and 5 minutes discussion)

15.10 – 15.30 Impact of newborn immunisation on the hepatitis B epidemiology in Kazakhstan. Raushan Idrisova

15.30 – 15.50 Experience with sentinel surveillance in Kyrgyzstan. Rafik Usmanov

15.50 – 16.10 Coffee Break

16.10 – 16.30 Hepatitis B prevention strategies in Moldova. Mihail Magdei

16.30 – 16.50 Hepatitis B prevention strategies in Poland, including safe injection management. Wieslaw Magdzik

16.50 – 17.10 Hepatitis B prevention strategies in the Russian Federation. Galina Lazikova

17.10 – 17.30 Children’s hepatitis B vaccine programme in Nizhni Novgorod, Russian Federation. Yelena Gudanova Download pdf file (approx.1430kb)

17.30 – 17.50 Lessons learned from Turkey. Selim Badur Download Powerpoint document (approx. 235kb)

17.50 – 18.00 Close of the day by the chair

Housekeeping Announcements

Social Activity - Dinner at the Nikolaevsky palace

Tuesday, 26 June 2001

Session 5 Strengthening immunisation systems and introduction of new vaccines

Chair: James Jones and Yevgeny Zagryadsky

09.00– 09.25 GAVI Regional Working Group & Status of GAVI Implementation. Denis Maire Download Powerpoint document (approx. 159kb)

09.25 – 09.50 In Country Coordination. Nedret Emirloglu Download Powerpoint document (approx. 175kb)

09.50 – 10.15 Discussion

10.15 – 10.40 Multi-Year Plans. Alexander Malyavin Download Powerpoint document (approx. 64kb)

10.40 – 11.05 Introduction of New Vaccines (example of Hib).Pem Namgyal Download Powerpoint document (approx. 236kb)

11.05 - 11.30 Discussion

11.30 – 11.50 Coffee break

11.50 – 12.15 Health Information Systems. Ljudmyla Muharska and Galina Shevschenko Download Powerpoint document (approx. 463kb) Download Powerpoint document (approx. 504kb)

12.15 – 12.40 Financing Multi-Year Plans. Alan Brooks Download Powerpoint document (approx. 108kb)

12.40 – 13.10 Discussion

13.10 – 14.30 Lunch

Session 6 Country Workshops

Chair: Johannes Hallauer

Focus on:

14.30 – 18.00 4 break-out groups

    1. Albania, Bosnia-Herzegovina, Kazakhstan, Kyrgyzstan, Tadjikistan, Turkmenistan, Uzbekistan (language: English/Russian)
      Chair: Sergei Deshevoi Co-chair: Michael Favorov Rapporteur: Eugene Zhiburt and Irkin Musabaev
    2. Belarus, Armenia, Azerbaijan, Georgia, Moldova, Russian Federation, Ukraine (language: English/Russian)
      Chair: Petru Jarovoi Co-chair: Alexander Malyavin Rapporteur: Sergey Mukomolov and Denis Maire
    3. Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Slovakia, Slovenia (language: English)
      Chair: Gustav Walter Co-chair: Johannes Hallauer Rapporteur: David Mercer
    4. Bulgaria, Croatia, FYROM, Romania, Yugoslavia, Turkey (language: English)
      Chair: Mira Kojuharova Co-chair: Peter Grob Rapporteur: Molly Mort

Wednesday, 27 June 2001

Session 7 Feedback Country Break-Outs

Chair: Nedret Emiroglu and Michael Favorov

09.00 – 09.20 Feedback country workshop I

09.20 – 09.35 discussion

09.35 – 09.55 Feedback country workshop II

09.55 – 10.10 discussion

10.10 – 10.40 Coffee Break

10.40 – 11.00 Feedback country workshop III

11.00 – 11.15 discussion

11.15 – 11.35 Feedback country workshop IV

11.35 – 11.50 discussion

11.50 – 13.00 Lunch

Session 8A Workshop on Global Fund

Chair: Mark Kane

Facilitator: Alan Brooks Download Powerpoint document (approx. 295kb)

13.00 – 14.00 Global Fund sub-accounts and application process

14.00 - 15.00 Discussion

15.00 – 15.15 Coffee Break

15.15 – 16.00 What happens after an application is approved
On-going monitoring and reporting

16.00 – 17.00 Discussion

Session 8B Workshops on Technical aspects of Hepatitis B prevention and vaccination

Chair: Paolo Bonanni and Daniel Lavanchy

13.00 – 13.30 Safe immunisation practice and blood supply. NN and Eugene Zhiburt

13.30 – 13.55 Discussion

13.55 – 14.25 Technical aspects of hepatitis B vaccines: Susan Goldstein, Wolfgang Jilg, and Pierre Van Damme Download Powerpoint document (approx. 90kb) Download Powerpoint document (approx. 97kb)

14.25 – 14.50 Discussion

14.50 – 15.10 Coffee Break

15.10 – 15.40 Outcome evaluation of an universal hepatitis B immuniszation programme. Susan Goldstein and Johannes Hallauer Download Powerpoint document (approx. 140kb)

15.40 – 16.05 Discussion

16.05 – 16.35 Diagnostics and reagents. Peter Grob, Tatiana Kalachnikova, and Irkin Musabaev Download pdf file (approx. 1.017kb) Download Powerpoint document (approx. 540kb) Download Powerpoint document (approx. 337kb)

16.35 – 17.00 Discussion

Session 9 Conclusions of the Meeting and Closing Remarks

Chair: Nedret Emiroglu and Mark Kane

17.00 – 18.00 Conclusions and summary of the meeting David FitzSimons Download Powerpoint document (approx. 42kb)